Investigator
John Danias
SUNY DOWNSTATE MEDICAL CENTER · funded by NEI, VA
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $1.3M
- First award
- May 1, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Apr 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- WADSWORTH CENTERMomentum in another area
Grant-only
- VA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYNMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Elucidating the molecular changes of the outflow pathway extracellular matrix that regulate outflow facility in steroid-induced ocular hypertension and open angle glaucoma
$662kApr 1, 2025NEISUNY DOWNSTATE MEDICAL CENTERNIH RePORTER · 11028857 (opens the source filing in a new tab)
- R01
Elucidating the molecular changes of the outflow pathway extracellular matrix that regulate outflow facility in steroid-induced ocular hypertension and open angle glaucoma
$628kApr 1, 2025NEISUNY DOWNSTATE MEDICAL CENTERNIH RePORTER · 11302646 (opens the source filing in a new tab)
- I01
Tissue plasminogen activator for the treatment of glaucoma
May 1, 2023VAVA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYNNIH RePORTER · 11065469 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources